Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), in recognition of National Suicide Prevention Awareness Month, announced the launch of the NeuroStar Voices Portal, a platform aimed at fostering connections, sharing …
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced NeuroStar Advanced Therapy’s “Tap Into A New Possibility for Depression” campaign has been awarded Gold by the 2023 dotCOMM Awards …
NeuroStar Advanced Therapy Shines Bright, Triumphs at 2023 dotCOMM Awards Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company, this week announced enhancements to the TrakStar® Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting …
Neuronetics Unveils Enhanced TrakStar Patient Data Management System, Revolutionizing NeuroStar TMS Experience Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company, this week announced its financial and operating results for the second quarter of 2023.
Neuronetics Reports Record Second Quarter 2023 Financial, Operating Results Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company, recenlty announced the granting of inducement awards of Restricted Stock Units representing a total of 27,000 shares …
Neuronetics, Inc. Awards 27,000 Restricted Stock Units to New Non-Executives Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company, announced that it plans to release second quarter 2023 financial and operating results prior to market open …
Neuronetics to Report Second Quarter 2023 Financial, Operating Results and Host Conference Call Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM announced a healthcare policy update from Aetna that increases access for patients to the Company’s NeuroStar® Advanced Therapy.
Neuronetics Announces Expanded TMS Therapy Access Through Aetna Health Plans Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company, announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has authorized multiple features of NeuroStar …
NeuroStar Achieves Milestone Regulatory Clearance in South Korea Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) and mental health advocate Drew Robinson have won Gold for Best Use of Personality/Celebrity at the Bulldog PR Awards. Their partnership allowed them …
Neuronetics and Drew Robinson Win Gold at Bulldog PR Awards for Mental Health Partnership Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company, announced this week that they have received 510(k) clearance for their obsessive-compulsive disorder (OCD) Motor Threshold (MT) Cap technology …
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy Read More